Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,433,276 papers from all fields of science
Search
Sign In
Create Free Account
Coronary Artery Disease
Known as:
DISEASE CORONARY ARTERY
, Coronary Artery Disease [Disease/Finding]
, coronary heart disease
Expand
Narrowing of the coronary arteries due to fatty deposits inside the arterial walls. The diagnostic criteria may include documented history of any of…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
45 relations
Angina Pectoris
Arterial embolism and thrombosis
Cerivastatin sodium
Cholestyramine Resin 4000 MG Powder for Oral Suspension
Expand
Broader (3)
Generalized Arteriosclerosis
Heart Diseases
circulatory disorders
Narrower (2)
Left main stem disease
Non-Q wave myocardial infarction
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
Benjamin D. Parker
,
L. Schurgers
,
+6 authors
J. Ix
Annals of Internal Medicine
2010
Corpus ID: 207535843
BACKGROUND Fibroblast growth factor 23 (FGF23), uncarboxylated matrix Gla protein (ucMGP), and fetuin-A are regulators of mineral…
Expand
Highly Cited
2006
Highly Cited
2006
Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease.
T. Jernberg
,
C. Payne
,
+6 authors
L. Wallentin
European Heart Journal
2006
Corpus ID: 41135641
AIMS This study was designed to compare the degree of inhibition of platelet aggregation (IPA) of prasugrel with that of…
Expand
Highly Cited
2006
Highly Cited
2006
The risk of death associated with delayed coronary artery bypass surgery
B. Sobolev
,
Adrian R. Levy
,
Lisa Kuramoto
,
Robert Hayden
,
James M Brophy
,
J Mark FitzGerald
BMC Health Services Research
2006
Corpus ID: 7199149
BackgroundThe detrimental effect of delaying surgical revascularization has been estimated in randomized trials and observational…
Expand
Review
1998
Review
1998
Depression is a risk factor for coronary artery disease in men: the precursors study.
D. Ford
,
L. Mead
,
P. Chang
,
L. Cooper-Patrick
,
Nae-Yuh Wang
,
M. Klag
Archives of Internal Medicine
1998
Corpus ID: 32770520
BACKGROUND Several studies have found that depression is an independent predictor of poor outcome after the onset of clinical…
Expand
Highly Cited
1996
Highly Cited
1996
Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification.
R. Hachamovitch
,
D. Berman
,
+4 authors
G. Diamond
Circulation
1996
Corpus ID: 45236141
BACKGROUND We evaluated the incremental prognostic value, the role in risk stratification, and the impact on patient management…
Expand
Highly Cited
1995
Highly Cited
1995
Thyroid hormone treatment after coronary-artery bypass surgery.
J. Klemperer
,
I. Klein
,
+5 authors
K. Krieger
New England Journal of Medicine
1995
Corpus ID: 23057680
BACKGROUND Thyroid hormone has many effects on the cardiovascular system. During and after cardiopulmonary bypass, serum…
Expand
Highly Cited
1992
Highly Cited
1992
Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease.
Redford B Williams
,
J. Barefoot
,
+6 authors
D. B. Mark
Journal of the American Medical Association (JAMA…
1992
Corpus ID: 3699752
OBJECTIVE To evaluate the hypothesis that diminished social and economic resources impact adversely on cardiovascular mortality…
Expand
Highly Cited
1991
Highly Cited
1991
Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease.
Soo-Sang Kang
,
P. Wong
,
A. Susmano
,
Judy Sora
,
Marija Norusis
,
N. Ruggie
American Journal of Human Genetics
1991
Corpus ID: 20773734
Severe methylenetetrahydrofolate reductase (MTHFR) deficiency with less than 2% of normal enzyme activity is characterized by…
Expand
Highly Cited
1990
Highly Cited
1990
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.
Greg B. Brown
,
J. Albers
,
+7 authors
H. Dodge
New England Journal of Medicine
1990
Corpus ID: 19429400
BACKGROUND AND METHODS The effect of intensive lipid-lowering therapy on coronary atherosclerosis among men at high risk for…
Expand
Highly Cited
1983
Highly Cited
1983
Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease.
J. Maciejko
,
D. Holmes
,
B. Kottke
,
A. Zinsmeister
,
D. Dinh
,
S. Mao
New England Journal of Medicine
1983
Corpus ID: 26475538
This study was designed to determine whether the plasma level of apolipoprotein A-I is a better discriminator of angiographically…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE